23 Recruiting Acute Lymphoblastic Leukemia Phase 1 Clinical Trials
Active phase 1 studies for acute lymphoblastic leukemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Acute Lymphoblastic Leukemia studiesPhase 1 Studies for Acute Lymphoblastic Leukemia
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
📍 Emory University Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Administration of Donor T Cells With the Caspase-9 Suicide Gene
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
📍 University of Chicago Medical Center — Chicago, Illinois
View Study & Checklist ➔Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
📍 Vancouver General Hospital — Vancouver, British Columbia
View Study & Checklist ➔CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
View Study & Checklist ➔The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
View Study & Checklist ➔